Previous Article | Next Article ![]()
Journal of Virology, June 2001, p. 5614-5626, Vol. 75, No. 12
Molecular Virology Program, Department of
Oncology, The Johns Hopkins University School of Medicine Cancer
Center, Baltimore, Maryland 21231
Received 20 November 2000/Accepted 20 March 2001
Angiogenic Kaposi's sarcoma (KS) skin lesions found in both AIDS
and non-AIDS patients are universally associated with infection by the
presumed causative agent, known as KS-associated herpesvirus (KSHV) or
human herpesvirus 8. KSHV genomes expressing latent state virus-encoded
mRNAs and the LANA1 (latent nuclear antigen 1) protein are consistently
present in spindle-like tumor cells that are thought to be of
endothelial cell origin. Although the KSHV lytic cycle can be induced
in rare latently infected primary effusion lymphoma (PEL) cell lines,
the ability to transmit or assay infectious KSHV has so far eluded
investigators. Here, we demonstrate that infection with supernatant
virions derived from three different tetradecanoyl phorbol
acetate-induced PEL cell lines can induce cultured primary human dermal
microvascular endothelial cells (DMVEC) to form colonies of
proliferating latently infected spindle-shaped cells, all of which
express the KSHV-encoded LANA1 protein. Although their initial
infectivity varied widely (JSC1 > > BC3 > BCP1), virions
from all three cell lines produced distinctive spindle cell colonies
and plaques without affecting the contact-inhibited cobblestone-like
phenotype of adjacent uninfected DMVEC. Each infected culture could
also be expanded into a completely spindloid persistently infected
culture displaying aggregated swirls of spindle cells resembling those
in KS lesions. Formation of new colonies and plaques was inhibited in
the presence of phosphonoacetic acid or gangciclovir, but these
antiherpesvirus agents had little effect on the propagation of already
latently infected spindloid cultures. In persistently infected
secondary cultures, patches of up to 10% of the spindloid cells
constitutively expressed several early viral lytic cycle proteins, and
1 to 2% of the cells also formed typical herpesvirus DNA replication
compartments, displayed cytopathic rounding effects, and expressed late
viral antigens. We conclude that de novo KSHV infection
induces a spindle cell conversion phenotype in primary DMVEC cultures
that is directly associated with latent state expression of the LANA1
protein. However, these cultures also spontaneously reactivate to
produce an unusual combination of both latent and productive but slow lytic cycle infection. The formation of spindle cell colonies and
plaques in DMVEC cultures provides for the first time a quantitative assay for directly measuring the infectivity of KSHV virion preparations.
Classic Kaposi's sarcoma (KS) is a
rare angiogenic skin lesion found primarily in males in the
Mediterranean area and in central Africa where KS-associated
herpesvirus (KSHV) infection is common. However, in the setting of
combined immunosuppression and KSHV infection in renal transplant
patients or of both human immunodeficiency virus and KSHV infection in
AIDS patients, the rates of KS increase 500- and 20,000-fold,
respectively, compared to ethnically matched populations. The higher
rate in AIDS patients is at least partly explained by much higher KSHV
infection rates in male homosexual AIDS patients (up to 85%) compared
to the average U.S. or U.K. population (0.5 to 2%). KS is now the most
abundant tumor found in many parts of central and southern Africa and
can occasionally become highly invasive and aggressive. KSHV DNA is
invariably found in KS tumors (9, 16, 33), and viral mRNAs
for the latent state LANA1 (latent nuclear antigen 1), vCYC-D, and
vFLIP genes, as well as the T0.7 transcripts, are found consistently in
spindle cells in late-stage nodular or invasive tumors as well as in at
least some cells of early-stage plaque and patch lesions (10,
29). Some reports also describe scattered single cells in some
tumors that express presumed lytic cycle viral mRNAs for viral
interleukin-6 (vIL6), viral macrophage inflammatory protein 1 (vMIP1),
T1.1, or ORF23 (28), but only LANA1 has been observed to
be expressed consistently in most spindle cells at the protein level.
KSHV genomes are also found consistently in multicentric Castleman's
disease (27) and in rare AIDS-associated primary effusion
lymphoma (PEL) tumors, several of which have been established as
permanent cell lines that stably maintain multicopy extrachromosomal KSHV plasmids or episomes (2, 5, 7).
The ability to induce lytic cycle KSHV infection including production
of some mature virions after tetradecanoyl phorbal acetate (TPA) or
sodium butyrate treatment of PEL cell lines has revolutionized study of
the molecular genetics and molecular biology of KSHV (19, 24, 26,
30); however, the ability to transmit virus from these cells to
other cultures or to assay infectious virus has been particularly
elusive. Two early studies claimed some degree of success in passing
very low levels of virus onto B lymphocytes and 293 cells
(12), but no cell type tested was susceptible in other
studies (23), and the evidence consisted only of DNA or
reverse transcription-PCR analysis at a level that most observers considered dubious at best. Another initial study used PCR procedures to suggest that KSHV DNA persisted for several months after addition of
supernatant virus from a PEL cell line culture to primary dermal microvascular endothelial cells (DMVEC) (21).
Subsequently, Flore et al. (11) documented a long-term
persistent infection of primary bone marrow-derived endothelial cells
(BMEC) using PEL supernatant virus. This system showed enhanced
longevity and acquisition of a spindle cell phenotype, although only
1% of the cells were thought to be infected, leading to a presumed
paracrine effect on surrounding surviving cells in the culture. More
recently, Moses et al. (17) used human papillomavirus
E6/E7-immortalized human DMVEC to establish a similar but more
completely infected system in which most cells became spindloid and
expressed LANA1.
Here we have used specific antisera directed against several
KSHV-encoded nuclear and cytoplasmic lytic cycle proteins to demonstrate that filtered supernatant virus from three PEL cell lines
can be used to infect contact-inhibited monolayers of primary human
DMVEC, resulting in single isolated colonies and plaques that can be
expanded into completely converted spindle cell cultures. These
infections could also then be efficiently propagated and passaged when
added to new DMVEC cultures in which all cells underwent spindle cell
conversion. All spindle cells expressed KSHV-encoded LANA1, and under
appropriate conditions clusters of up to 10% of the spindle cells were
spontaneously reactivated to express specific viral early lytic cycle
proteins, with a small subset of these progressing to develop
cytopathic effects (CPE) and form distinctive viral DNA replication
compartments typical of a full lytic cycle program.
PEL cell lines.
PEL cell lines BC3 (American Type Culture
Collection) (2) and BCP1 (American Type Culture
Collection) (5) were grown in RPMI medium (Gibco BRL,
Gaithersburg, Md.) supplemented with 20% Fetalclone I serum (HyClone).
The JSC1 PEL cell line established by Cannon et al. (6)
was grown in RPMI medium supplemented with 10% Fetalclone I. At the
time of use, these cell lines had spontaneous lytic reactivation levels
of 2, 0.5, and 25%, respectively, as measured by indirect
immunofluorescence array (IFA) for vIL6 and of 0.2, 0.1, and 4%,
respectively, as measured by IFA for the nuclear ORF59 DNA replication
protein. These values increased 5- to 10-fold for BC3 and BCP1 and
3-fold for JSC1 after TPA induction for 48 h.
DMVEC cultures.
Primary adult or fetal DMVEC were obtained
commercially (Clonetics Inc. HMVEC-d; catalog no. CC-2543) and grown in
EGM2-MV Bullet kit medium (Clonetics catalog no. CC-3202) containing
vascular endothelial growth factor (VEGF), basic fibroblast growth
factor, and epithelial growth factor and maintained as instructed.
These cells retained the ability to divide and form cobblestone-like contact-inhibited monolayers suitable for use in KSHV infection studies
for up to six passages.
Virus infection.
PEL cell line cultures (total of 1 × 108 to 3 × 108 cells at
106/ml) were induced with TPA at 20 ng/ml for 96 h.
Clarified supernatant were passed through a 0.45-µm-pore-size filter
(Millipore) to remove all cell debris, and the virions were pelleted by
high-speed centrifugation for 2.5 h at 4°C at 20,000 × g. The virus pellet was resuspended in 2 ml of
phosphate-buffered saline and used immediately to infect DMVEC cultures
that were approximately 80% confluent (100 µl per 25-cm2
flask). Fresh medium was added to the virus inoculum after a 2-h
adsorption step, and the culture medium was replaced every 48 h.
For long-term propagation of secondary KSHV-infected cultures, the
spindle cells were trypsinized and passaged as needed by seeding at a
1:10 ratio with uninfected DMVEC. For plaque assay experiments, the
culture dishes were washed and fixed after 22 to 35 days and stained
with crystal violet. The amounts of DNase I-resistant KSHV DNA in the
resuspended virus pellet preparations were measured by a quantitative
PCR procedure using the original supernatant from the TPA-treated JSC1,
BC3, and BCP1 PEL cell cultures (6). The herpesvirus DNA
replication inhibitors phosphonoacetic acid (PAA; Sigma) at 400 µg/ml
and ganciclovir (GCV; Hoffman-LaRoche Inc. Nutley, N.J.) at 50 µg/ml
were used to block lytic cycle events.
Antibodies.
Rabbit polyclonal antibodies recognizing
KSHV-encoded proteins were generated against selected synthetic
peptides conjugated to keyhole limpet hemocyanin as described
previously (31). The specific peptides used were as follows: vIL6,
N-192-(Y)DSIPDVTPDVHDKR(SC)-204-C; ZMP-A (zinc finger
membrane protein A; ORF-K5),
N-242-(Y)PTKKPVRKNHPKNNG(SC)-256-C; and ORF-K8,
N-16-(Y)DNSEKDEAVIEED(SC)-28-C. Other specific KSHV antipeptide antibodies used included anti-LANA, anti-ZMP-B (ORF-K3), anti-SSB (ORF6), anti-viral G-protein-coupled receptor N terminus [vGCR(N)], anti-Rta (ORF50), and anti-Mta (ORF57). Mouse monoclonal antibodies (MAbs) directed against other KSHV-encoded proteins, including LANA (LN53) (13), ORF59 (primase-associated
factor [PAF]) (8), and ORF-K8.1 (32) were
kind gifts from Chris Boshoff (University College of London, London,
United Kingdom) and Bala Chandran (University of Kansas, Lawrence),
respectively. Mouse MAbs used included anti-E-cadherin and anti-Von
Willebrand factor (Santa Cruz Inc. Calif.).
IFA.
Infected or uninfected DMVEC were seeded into
two-chamber Lab-Tek slides with changes of medium every 48 h,
followed by fixation in methanol for IFA. Slides were stored at
IHC.
Immunohistochemical staining was also used to detect
viral protein expression in DMVEC spindle cell cultures grown directly in slide chambers for 3 days and then fixed in 50% methanol-50% acetone ( Formation of spindle cell colonies and plaques in DMVEC cultures
infected with supernatant virus from induced BC3 cells.
Human
primary DMVEC cultures grown in the presence of VEGF, basic fibroblast
growth factor, and epithelial growth factor formed cobblestone-like
monolayers of contact-inhibited cuboidal cells that could be stably
maintained with frequent medium changes over a period of up to 6 weeks.
To examine possible effects of KSHV infection in these cells, filtered
supernatant virion preparations from three different PEL cell lines
that had been treated with TPA for 96 h were pelleted and
resuspended and then added to subconfluent DMVEC cultures in
25-cm2 plaque dishes. One such DMVEC culture receiving 100 µl of pelleted virus from TPA-treated BC3 cells produced four
discrete colonies of spindle-shaped cells at 25 days, two of which
reached 0.5 cm in size and had large cytopathic areas in the center
(Fig. 1A). Two smaller
colonies consisted of up to 1000 spindle cells each but lacked
cytopathic areas. At higher power, highly bunched spindle cells can be
seen piling up as a circular colony adjacent to the otherwise
unaffected monolayer cells (Fig. 1B). A parallel DMVEC culture that
received an equal volume of the same BC3 supernatant virus was
subsequently passaged by trypsinization and mixing with a 10-fold
excess of fresh uninfected DMVEC, yielding a secondary culture with
more than 500 spindle cell colonies at 14 days. Infection of this
culture then progressed further so that by 24 days all cells displayed
a spindle cell phenotype. A similar 100 µl sample of pelleted
supernatant material from TPA-treated BCP1 cells failed to produce any
detectable spindle colonies or spindle plaques at the first passage.
Nevertheless, this latter culture gave 70 discrete plaques from a 1:10
dilution into fresh DMVEC at second passage, indicating the presence of
at least one cryptic infectious center in the initial culture plate
(not shown). In contrast, parallel second-passage cultures from
uninfected DMVEC monolayers consistently failed to produce any evidence
of a spindle cell phenotype.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.12.5614-5626.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Spindle Cell Conversion by Kaposi's Sarcoma-Associated
Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and
Latent Gene Expression in Infected Primary Dermal Microvascular
Endothelial Cell Cultures
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
20°C. For secondary culture lytic cycle IFA, KSHV-converted spindle
cells were mixed with a 10:1 excess of uninfected DMVEC and grown for 7 to 10 days before fixation. Primary rabbit polyclonal antibodies (PAbs)
were diluted 1:400 in 2% normal goat or donkey serum in
phosphate-buffered saline and (Ca and Mg free), ORF59 and LANA1 MAbs
obtained as cell culture supernatants were diluted 1:100, and
conjugated secondary antibodies (affinity purified and absorbed for the
appropriate dual-label studies; Chemicon) were diluted 1:100. Primary
antibodies were incubated for 2 h at 37°C, and secondary
antibodies were incubated for 30 min at 37°C.
20°C, 10 min) for IHC. In one experiment for LANA1 IHC assays, PEL supernatant virus was added (25 µl/well), and the primary
infected cultures were incubated for various times up to 28 days
(6). Rabbit anti-vIL6, anti-ORF-K8, anti-ZMP-A, or
anti-vGCR(N) PAb and mouse anti-ORF K8.1 or rat anti-LANA MAb were
applied at a 1:1,000 dilution in blocking solution and incubated for
18 h. Immunodetection of rabbit PAbs was carried out using alkaline phosphatase conjugate followed by Vector red phosphate chromagen (Vector Laboratories, Burlingame, Calif.). Immunodetection of
mouse MAbs was carried out using streptavidin-biotin with a horseradish
peroxidase conjugate (DAKO) and diaminobenzidine (DAB) color
development. For double-label IHC assays, the MAb peroxidase-DAB reactions were carried out first, followed by the PAb alkaline phosphatase-Vector red reactions. Hematoxylin counterstain was applied
for all IHC assays.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (68K):
[in a new window]
FIG. 1.
KSHV infection of contact-inhibited DMVEC cultures
produces either colonies and plaques or total conversion to an
elongated spindle cell phenotype. (A) Plaque dish assay for infectious
KSHV in primary human DMVEC monolayer cultures showing four individual
spindle cell colonies (circled) that developed 25 days after infection with a 100-µl sample of pelleted filtered
supernatant virions from TPA-treated BC3 PEL cells. The two largest
colonies contain large central patches showing CPE (= plaques).
(Crystal violet stain.) (B) Medium-power photomicrograph of the top
edge of one of the two smaller BC3 colonies from panel A, containing
several hundred spindle cells and showing the boundaries of the colony
with adjacent cobblestone-like areas of uninfected DMVEC. (Crystal
violet stain; 16× objective.) (C) Control cobblestone-like monolayer
of cuboidal contact-inhibited DMVEC 20 days after addition of 100 µl
of resuspended pelleted material from the filtered supernatant of
untreated JSC1 cells. (Crystal violet stain; 16× objective.) (D)
Parallel culture of completely, spindle cell-converted DMVEC
photographed at 20 days after receiving 100 µl of resuspended
pelleted KSHV virions from the filtered supernatant of TPA-treated JSCI
cells. (Crystal violet stain; 16× objective.)
Complete spindle cell conversion of cultured endothelial cells by supernatant virus from the induced JSC1 PEL cell line. In contrast to the discrete colonies produced from BC3 cells, addition of filtered and pelleted supernatant virions from JSC1 PEL cells (6) led to dramatic changes in the morphology of all cells in the DMVEC culture within 14 to 20 days. Photomicrographs of cells stained with crystal violet at 24 days from two parallel dishes that received 100 µl of resuspended pelleted material from either untreated or TPA-treated JSC1 supernatants are shown in Fig. 1C and D. Both the control uninfected culture and the cells receiving the untreated pellet (Fig. 1C) gave an unaltered flat uniform cobblestone appearance with occasional patches of syncytium formation. However, the sample receiving pelleted virions from TPA-treated JSC1 cells (Fig. 1D) produced an altered pattern, with all cells in the culture showing an elongated spindloid morphology with swirls of aligned cell clusters. A parallel culture receiving 500 µl of pelleted supernatant JSC1 virions produced even more aggregated and piled-up swirls of proliferating spindle cells that stained heavily (not shown).
Spindle cell-converted DMVEC cultures can be propagated
continuously by addition to fresh uninfected DMVEC cultures.
After
10 passages over 4 months, the JSC1-infected DMVEC spindle cell
cultures deteriorated and could not be established as a continuous cell
line. However, when split and passaged 1:10 with fresh cultures of
uninfected DMVEC, which then also all acquired a spindle cell
morphology after 7 to 10 days (Fig. 2A),
the infected cultures could be maintained and
propagated indefinitely. Parallel uninfected DMVEC cultures remained
contact inhibited but became difficult to passage and lost viability
after 6 to 8 passages. The secondary BC3 spindle cell phenotype could
also be passaged continuously as a completely spindle cell-converted
culture by addition of fresh uninfected DMVEC.
|
Evidence that all spindle cells in the DMVEC culture are latently
infected.
Flore et al. (11) suggested that in their
BMEC system adjacent uninfected cells were converted to spindle cells
by paracrine effects produced by factors secreted from the relatively
small proportion (1%) of KSHV-infected cells present. They also showed that apparently virus-free supernatants from the infected culture could
be used to convert human umbilical vein endothelial cell cultures to a
spindle cell phenotype, although it was not clear how long these could
be maintained in the absence of infection. In contrast, in our system,
there did not appear to be any kind of soluble paracrine effects
involved because of the ability to maintain normal cobblestone
monolayers directly adjacent to spindle cell colonies and plaques for
long periods of time (Fig. 1A and B). Therefore, we investigated the
alternative possibility that all spindle cells in the DMVEC cultures
may harbor a latent state infection. Completely converted JSC1 or BC3
spindle cell cultures were grown directly in microscope slide chambers
and processed for IFA after 3 days. Two different antibodies directed
against the KSHV latent nuclear antigen protein LANA1, which both gave nuclear IFA signals in the majority of the cells in PEL cell lines, were used, and the results revealed that essentially all converted spindle cells were LANA1 positive by IFA with anti-LANA1 antibody (Fig.
2D). To more convincingly demonstrate that only cells with the spindle
phenotype correlate with LANA1 expression, we also examined LANA1
staining by IHC at 17 days after primary infection of a DMVEC culture
with just 25 µl of pelleted JSC1 virions. In this experiment (Fig.
2B), virtually all cells in two typical adjacent spindle cell colonies
of 30 to 80 cells each (one oval and the other highly elongated)
displayed LANA1-positive nuclei, whereas the adjacent cobblestone
monolayer cells in the same culture were all negative for LANA1. In
most spindle cells in both primary and secondary infected cultures,
both rat MAb and rabbit PAb specific to LANA1 gave characteristic
punctate nuclear patterns (visible at higher magnification by IFA and
IHC in Fig. 3A and B), which probably
represent the LANA1 protein bound to multiple copies of episomal viral
genomes (4).
|
Titration of KSHV PFU.
In an attempt to assay the number of
infectious virions present in the JSC1 PEL cell line supernatant, a
parallel dish of DMVEC receiving 25 µl of pelleted supernatant virus
yielded 73 discrete spindle cell colonies after 17 days. Therefore, the
titer of infectious KSHV from the original JSC1 cells in this
experiment was measured at 2.9 × 103 PFU/ml (Table
1, experiment 1). Again, a completely
infected spindle cell-converted culture was obtained after the second
passage as a 1:10 dilution with fresh DMVEC. A similar result was
obtained in an experiment in which filtered and polyethylene
glycol-precipitated virions from TPA-treated JSC1 supernatants were
compared to a pelleted filtrate from washed and freeze-thawed JSC1
cells, which both gave titers measured in dilution series of 4 × 103 to 5 × 103 PFU/ml (Table 1,
Experiment 2). During a second passage from one of these infected
cultures, 100 µl of unpelleted filtered DMVEC supernatant (without
any TPA treatment) gave 400 colonies and plaques on a fresh monolayer
of DMVEC at 17 days (Table 1, Experiment 2A), whereas the infected
cells themselves gave a completely spindloid culture after a 1:10
split. Again, the second passage from an uninfected DMVEC monolayer
failed to do so. Considering that all dishes received complete medium
changes every 2 days, this result indicated that the spindle cell
cultures were themselves producing new progeny infectious cell-free
virions in the absence of TPA induction.
|
Blocking of infection and spindle cell conversion with viral DNA synthesis-inhibitors. To assess whether new viral DNA synthesis was necessary for formation of colonies and plaques, pelleted virus from the filtered supernatant from TPA-treated JSC1 cells was added to a fresh culture of contact-inhibited DMVEC in the presence or absence of either PAA or GCV, and the cultures were fixed and stained at 21 days. In this case, undiluted virus from a TPA-treated culture again gave complete spindle cell conversion, and titers in diluted samples in the absence of inhibitors were measured at 5 × 103 PFU/ml (Table 1, Experiment 3). However, in the presence of PAA, the spindle cell conversion was totally abolished, the DMVEC cells remained contact inhibited, and no plaques or colonies were obtained. In the presence of GCV, a moderate number of small spindloid plaques (200 PFU/ml) were obtained. In contrast, addition of PAA to an already completely converted spindle cell culture for a period of 17 days had no obvious effects on the spindle cell phenotype. Evidently, initiation of colony or plaque formation requires lytic cycle virus growth in the DMVEC, but continued proliferation of the spindle cell colonies once initiated probably does not require lytic cycle events.
Expression of early lytic cycle proteins in KSHV-infected DMVEC
spindle cell cultures.
After several weeks in culture, both the
completely converted spindle cell DMVEC and the individual larger
spindle cell colonies frequently developed plaque-like patches or
clusters of cells with a rounded cytopathic phenotype (Fig. 1A and 2C).
Staining for DNA with 4',6-diamidino-2-phenylindole suggested that
these latter cells did not have the fragmented nuclear bodies typical of cells undergoing apoptosis. These findings, together with the ability to passage the spindle cell phenotype with filtered DMVEC supernatants, suggested that some cells have been undergoing
spontaneous virus lytic cycle replication. Therefore, we examined
whether a variety of early and late viral lytic cycle proteins were
being expressed. Initially, both IFA and IHC with rabbit PAb or mouse MAbs directed against several early nuclear or cytoplasmic KSHV-encoded proteins, including vIL6, ORF-K8, SSB (ORF6), vGCR (ORF74), ZMP-A (ORF-K5), and ORF59 (PAF), were carried out directly at 3 days after
replating undiluted spindle cultures in slide chambers. Typical results
for both IFA and IHC detection are shown for nuclear ORF-K8 (Fig. 3E;
Fig. 4C and D) and
cytoplasmic ZMP-A (Fig. 3F; Fig. 4A and B), which are
both among the earliest lytic cycle KSHV proteins expressed after TPA
induction in PEL cell lines. These two proteins were both expressed in
between 5 and 10% of all cells in the cultures. Most of the early
lytic antigen-positive cells remained spindloid, indistinguishable in
morphology from those expressing LANA1 only. Some spindle cells gave a
punctate nuclear ORF-K8 pattern (not shown), which is typical of the
very earliest stages of induction in PEL cells and represents
colocalization with PML oncogenic bodies (31). Unlike in
PEL cells (6, 15, 18), vIL6 was relatively difficult to
detect by IFA in these cultures, but some spindle cells (many fewer
than for K8 or ZMP-A) were also strongly positive for the two viral
delayed-early nuclear DNA replication proteins SSB and ORF59 (see
below), as well as for the delayed-early vGCR membrane signaling
protein (C.-J. Chiou et al., submitted for publication).
|
Loss of LANA1 and von Willebrand factor signals in cells undergoing lytic cycle. Double-label IFA experiments were also carried out in infected DMVEC spindle cell cultures to compare the distribution of cells expressing the cytoplasmic early lytic protein ZMP-A with those expressing the latent state nuclear protein LANA1. The results revealed that although the majority of spindle cells still showed typical nuclear punctate LANA1 patterns, some of the same subset of spindle cells that had entered the lytic cycle as judged by expression of cytoplasmic ZMP-A were now negative for LANA1 (not shown). Therefore, cells that have entered the lytic cycle evidently tend to lose the punctate LANA1 IFA patterns that are characteristic of the latent state, and the few cells that were both LANA1 and ZMP-A positive probably represent just the very earliest stages of lytic cycle reactivation.
To confirm that both the latent and lytic KSHV-infected cells were indeed endothelial cells and to begin to address whether any changes in endothelial cell markers were occurring in the infected spindle cells, we also carried out double-label IFA staining for von Willebrand factor and LANA1 in a partially converted spindle cell culture (Fig. 3C and D). Almost all uninfected DMVEC showed strong staining of Weibel-Palade bodies in the cytoplasm, as expected. However, although some spindle cells still retained significant von Willebrand factor, many LANA1-positive spindle cells displayed fewer Weibel-Palade bodies and much less overall positive signal for von Willebrand factor. Loss of von Willebrand factor staining was especially pronounced for a small subset of rounded cells expressing late lytic cycle antigens (not shown; see below). Uninfected DMVEC were also all positive for the E-cadherin endothelial cell marker, but its expression was not appreciably affected by KSHV infection or spindle cell phenotype (not shown).Development of CPE correlates with late lytic cycle protein
expression and formation of viral DNA replication compartments.
In
other experiments, secondary infections were carried out by plating a
mixture of completely spindloid KSHV latently infected DMVEC with a
10-fold excess of added fresh uninfected DMVEC in microscope slide
chamber dishes. After 7 to 10 days of growth, these cultures became
completely spindloid, but also developed small patches of between 4 and
20 adjacent cells that all expressed early K8 or ZMP-A protein.
Interestingly, often a small subset of these clustered early
antigen-positive cells had also rounded up, showing typical
herpesvirus-like CPE and forming miniplaques. Significantly, within
these clusters all of the cytopathic cells that had lost their spindle
phenotype still proved to be expressing KSHV lytic cycle antigens by
IFA, including both the K8 and ORF59 nuclear proteins (Fig. 5A and
B), as well as the early membrane protein ZMP-A (Fig. 5C and D). Furthermore, expression
of the true late lytic virion component glycoprotein ORF-K8.1 was found to occur only in the few cells showing CPE. For example, Fig. 2D shows
a completely converted spindle cell secondary culture containing cells
with CPE after direct reseeding for 3 days in a slide chamber culture
dish. Again, double-label IHC revealed expression of the ORF-K8.1
protein only in a dispersed subfraction of rounded lytic cells showing
CPE (red cytoplasm), in contrast to positive LANA1 nuclear expression
patterns in all spindle cells in the culture (brown nuclei).
Double-label IFA experiments also revealed that in the 10-day secondary
infected spindle cell cultures, both ORF59 and SSB were found
predominantly within the subsets of ZMP-A-positive spindle cells, as
well as in all rounded cells (not shown), whereas ORF-K8 and ZMP-A were
also present in other adjacent cells that remained spindloid and did
not yet express either ORF59 or SSB (Fig. 5A to C). Overall, although
clusters of up to 10% of the cells were often positive for early lytic proteins, the fraction that showed CPE and true late antigen expression rarely totaled more than 1 to 2% of all cells in the culture.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have shown here that cultured primary human DMVEC cultures can be infected at different efficiencies by KSHV virions derived from several PEL cell lines. The infection causes a phenotype involving aligned and swirling bunches of elongated spindle-shaped cells that closely resembles that displayed by the pathogenic spindle cells of nodular KS lesions. Importantly, KSHV infection of the DMVEC cultures and the associated spindle cell conversion phenotype correlate almost completely with constitutive LANA1 protein expression in the same cells. Recent studies by Dupin et al. (10) have also confirmed that almost all spindle cells in late nodular KS lesions express LANA1. The similarity to the latent state found in both PEL cell lines and KS lesions is emphasized by the punctate nuclear character of the LANA1 signal (4), implying that the viral genomes also establish a multicopy episomal state in infected spindloid DMVEC. However, although the KSHV-infected spindle cells have high mitotic indices and clearly proliferate (6), they could be propagated directly only for a few weeks and several passages longer than the parent uninfected DMVEC cells and did not appear to be truly immortalized or oncogenically transformed. In contrast, the infected spindloid cell phenotype could be passaged and maintained continuously by addition of either infected cells or cell-free supernatant to fresh uninfected DMVEC cultures, suggesting that in addition to proliferation of the latently infected spindle cells, low levels of progeny infectious virions are produced that can spread the spindle phenotype to adjacent uninfected cells.
We have also demonstrated directly that patches of spontaneous lytic infection rather than just latent infection occur within the KSHV-infected DMVEC spindle cell cultures and have adapted the system to demonstrate for the first time that infectious KSHV virions can be titered by an infectious center assay involving mixed spindle cell colony and plaque formation. Extensive IFA and IHC evidence confirmed that spontaneous lytic cycle induction occurs in a significant subfraction (5 to 10%) of the spindle cells and that most of the same early and late lytic cycle viral proteins that can be induced by TPA or butyrate treatment of PEL cell lines are synthesized over a relatively long time course that includes a second morphological change to a rounded CPE phenotype at late stages. Under appropriate undisturbed culture conditions, including the 10-day 1:10-diluted secondary cultures, small clusters or plaques of cells with CPE expressing late viral proteins develop within otherwise completely converted spindle cell cultures.
Several previous studies have provided preliminary evidence that supernatant KSHV derived from PEL cell lines or from fresh KS lesion biopsies may be able to persist at minimal levels in both infected 293 cells and primary DMVEC but not in numerous other cell types tested (12, 21, 23). However, that evidence consisted only of very low level viral DNA or RNA positivity by PCR. Flore et al. (11) provided provocative evidence that PEL supernatant KSHV could be used to produce a continuously passageable spindle phenotype in BMEC cultures. Evidently, only a small subfraction of these cells carried the virus, but this was associated with increased longevity of the whole culture, apparently involving paracrine effects on adjacent cells. Obviously, our system does not show the same disseminated paracrine effects as described by Flore et al. (11) because the spindle phenotype occurs only in infected DMVEC, but the moderately extended life span of the latently infected DMVEC spindle cell cultures without becoming immortalized or transformed somewhat resembles the overall effect seen in their BMEC system. Like the BMEC system (11), only a small subfraction (0.1%) of the KSHV-infected spindloid DMVEC produced colonies in soft agar assays (not shown), and these were small (0.2- to 0.4-mm diameter) compared to agar colonies grown from the same DMVEC cultures after infection with an E6/E7/Neor retrovirus.
Moses et al. (17) described a system more similar to ours, except that PEL supernatant virus was used to infect human papillomavirus E6/E7-immortalized DMVEC cultures. In their experiments also, most cells appeared to become latently infected and LANA-positive cells produced a spindloid morphology, but assayable plaque and colony formation was not demonstrated. In both the Flore and Moses systems, some preliminary evidence for both lytic cycle induction by TPA treatment and passaging of virus was presented, but we have shown here that in the primary DMVEC system both K8 and ZMP-A viral lytic cycle protein expression occurs spontaneously after 2 to 3 weeks in the center of large spindle cell colonies as well as in small clusters (totaling 5 to 10% of all cells) within 7 to 10 days after confluency in fully spindloid cultures or in secondary 1:10-diluted cultures. Furthermore, a subfraction of these cells (totaling 1 to 2% of all cells) also show typical herpesvirus rounding and CPE and express the true late lytic ORF-K8.1 glycoprotein, as well as containing active viral DNA replication compartments that colocalize with the ORF59 (PAF) viral DNA polymerase-associated protein. Finally, we have shown elsewhere by transmission electron microscopy studies (20) that the rounded lytically infected DMVEC showing CPE also contain numerous herpesvirus-like filled and empty capsids in the nucleus, as well as enveloped virions in the cytoplasm and endoplasmic reticulum and in adjacent extracellular spaces. We have not been able to establish a permanent latently infected DMVEC line, perhaps because the cultures eventually succumb to spontaneous lytic cycle reactivation.
Although the most efficient infection was established with supernatant virions derived from the JSC1 PEL cell line, which carries latent state Epstein-Barr virus (EBV) in addition to KSHV (6), similar mixed latent and lytically infected spindle cell cultures could also be established from KSHV virions derived from two PEL cell lines (BC3 and BCP1) that do not carry EBV genomes. The higher plaque titers and relative ease with which complete spindloid cultures could be obtained in our studies with virus from the JSC1 cell line is at least partially explained by the production of greater numbers of progeny supernatant virions (6), although there may be a qualitative effect as well. A number of observations support this conclusion. First, uninduced JSC1 cells consistently display higher spontaneous early lytic antigen expression levels of 20 to 30% vIL6-positive cells, compared to 0.3, 2, 2, and 0.5%, respectively, for spontaneous vIL6-positive cells in the BC1/HBL6, BC3, BCP1, and BCBL1 cell lines. Second, uninduced JSC1 cells also show much further progression of the lytic cycle compared to BC1/HBL6, BC3, BCP1, and BCBL1, cells, as assayed by the presence of vGCR (ORF74) protein-positive cells (3 to 5%) and by the numbers of cells that have ORF59-positive DNA replication compartments (1 to 3%); however, even uninduced JSC1 cells are still negative for the late ORF-K8.1 protein and evidently do not release infectious virions. Third, uninduced JSC1 cells contain considerably higher KSHV viral DNA copy numbers per microgram of total cell DNA compared to BC3, BCP1, and BCBL1 cells (as measured by Southern blot hybridization [not shown]). Fourth, although TPA treatment greatly increases all measures of lytic infection in all five cell lines, the others still produce relatively few fully lytic cells, as judged by ORF-K8.1 expression values of only 1 to 5%, compared to 20% for JSC1 cells.
Direct measurements of virion-associated KSHV DNA levels by quantitative PCR after DNase I treatment and lysis (6) also revealed the presence of 2 orders of magnitude more DNase I-resistant KSHV DNA in our pelleted TPA-induced JSC1 cell supernatants (2.5 × 106 genome equivalents/ml) compared to parallel TPA-treated BC3 or BCP1 supernatant virion preparations (2.5 × 104 genome equivalents/ml). These were the same pelleted supernatant virion preparations that were used here for the DMVEC infectivity assays that showed 100- and 500-fold-higher titers of infectious centers for JSC1 compared to BC3 and BCP1, respectively (Table 1). These results allow calculations of particle to PFU ratios of approximately 500:1 for JSC1 and BC3 and 2,500:1 for BCP1.
The quality in addition to quantity of viral genomes from JSC1 cells may also be different because in time course studies with low input doses of supernatant virus, the BC3 virus-infected DMVEC cultures took up to 22 days before any cells became LANA1 positive, whereas cultures receiving diluted JSC1 virus took only 4 days to initiate multiple LANA1-positive colonies (6). Genotypically, the K1 and K15 (22) subtypes of the three KSHV strains in question here are C3/P, C3/P and A1'/P, respectively, which seems less likely to be important than other factors. For example, one could imagine a situation similar to that encountered with the P3HR-1 lymphoblastoid cell line, in which defective tandemly repeated EBV genomes containing all three lytic cycle transactivator genes (Rta, Zta, and Mta) under the control of the rearranged latent state W and C promoters are packaged in the presence of wild-type helper genomes and give rise to persistent lytic cycle gene expression both in the P3HR1 cells themselves and in newly infected EBV-positive Raji cells. However, preliminary Southern blot analysis of several regions of the JSC1 genome has not shown any evidence for P3HR1-like tandem repeat DNA molecules. Furthermore, one would not expect to be able to successfully passage rearranged lytic JSC1 defective viruses onto fresh naive DMVEC cultures from filtered supernatant as we were able to do here.
Alternatively, some or all genomes in the extensively in vitro-passaged BC3 and BCP1 cell lines may be rearranged, deleted, or mutated in key lytic cycle genes, leading initially to reduced or cryptic reactivation or infectivity. For example, in BC1/HBL6 cells, the KSHV genome structure is known to be aberrant, with larger than usual 250-kb episomes consisting of 1.3 copies of the expected 180-kb viral genome and encompassing an extra set of the terminal tandem repeat sequences (25). Such genomes might not be packaged or infectious until after specific rearrangements occur. It is not known whether the BC3 or BCP1 episomal genome is also partially reiterated, but Southern blotting data with KSHV terminal tandem repeat unit DNA probes does not show any evidence for rearranged JSC1 episomal genomes (data not shown). Importantly, although between 100- and 500-fold less infectious virus was obtained initially from TPA-induced BC3 and BCP1 cell cultures than from the JSC1 cultures, both of the latter viruses could subsequently be maintained as easily passaged spindloid cultures, suggesting that once established in DMVECs all three viruses may produce equivalent levels of infectious centers or transmissible infectious particles.
There is also the point that because the JSC1 cells (unlike BC3 and BCP1 cells) contain episomal EBV genomes in addition to the KSHV genomes, it is possible that EBV contributes (directly or indirectly) to the apparently higher infectivity of the JSC1 cell line-derived virions. However, extensive evaluation of KSHV and EBV expression in the JSC1 cell line (6) has shown that any direct effects are extremely unlikely. First, as for other dually infected PEL cell lines such as BC1/HBL6 (14), the level of latent EBV gene expression in JSC1 cells is highly restricted. Second, the level of spontaneous and TPA-induced lytic cycle EBV gene expression (as measured by Zta protein expression) in JSC1 cells is extremely low (less than 0.1% of the cells). Third, there was between 10- and 100-fold less DNase I-resistant EBV DNA present in the JSC1 pelleted supernatant used for the DMVEC infectivity assays than there was KSHV DNA, as measured by quantitative DNA PCR (6). Fourth, parallel assays for EBV Zta protein expression by IFA in the DMVEC cultures were negative, and no EBV DNA (less than 20 copies in 104 cells) could be detected by quantitative PCR within the passaged JSC1-infected DMVEC cell cultures. Whether or not the presence of EBV in the parent JSC1 PELs may have indirect positive effects on the yields or quality of the KSHV virions obtained is difficult to assess at present, but in the BC1/HBL6 cell line at least, the effect of EBV on inducibility of the KSHV genomes by TPA is evidently negative.
As demonstrated by the LANA1 IFA, the majority of spindle cells in the KSHV-infected cultures appear to be equivalent to the latent state studied in uninduced PEL cell lines, including the presence of multicopy KSHV episomes associated with a punctate nuclear LANA1 distribution. Therefore, both the spindle phenotype and LANA1 expression are diagnostic of KSHV infection. However, in time course studies presented elsewhere (6), we found that small colonies of four to eight adjacent cuboidal DMVEC cells could be detected first by IHC for LANA1 protein expression within just 4 days after addition of JSC1 virus to DMVEC cultures. Although the cells in these earliest and smallest LANA1-positive colonies were not yet spindloid, by 6 and 9 days nearly all LANA1-positive cells in colonies of 10 to 30 cells in size were spindloid. Therefore, in establishing primary infection, LANA1 expression evidently precedes the spindle cell phenotype by several days.
Considering that the initial establishment of proliferating LANA1-positive converted spindle cells has all the hallmarks of true latent infection, the ability of PAA to totally block colony formation was quite surprising (Table 1). Future studies at the single-cell level will need to address de novo DMVEC infection with initial time course studies to determine when LANA1 first becomes punctate and what the effects of PAA treatment on LANA1 expression patterns are, as well as whether PAA blocks the apparent early episomal genomic DNA amplification events.
Most interestingly, both completely spindloid cultures and large spindle colonies often gave rise to occasional small patches of adjacent cells that showed a second morphological change, becoming rounded with typical herpesvirus CPE indicative of spontaneous lytic cycle reactivation. All of these cells proved to be undergoing KSHV DNA synthesis and late stage KSHV lytic viral antigen expression, as judged by BUdR incorporation and colocalization with the viral ORF59 replication fork protein in typical large subnuclear viral DNA replication compartments. These same 1 to 2% of the cells also showed positive expression of all lytic cycle KSHV-encoded viral proteins tested, including the true late ORF-K8.1 membrane glycoprotein (32), as well as the presence of abundant mature and immature herpesvirus particles (20). Furthermore, many additional spindle cells without CPE displayed spontaneous expression of just the earliest lytic proteins, including ZMP-A and K8. These often amounted to 5 to 10% of all spindle cells in 7- and 10-day secondary diluted cultures and often themselves formed additional small clusters or lay adjacent to cells with CPE. These latter cells may either represent a high fraction of abortive lytically infected cells that are unable to progress to later stages of the lytic cycle or, more likely, indicate that the lytic cycle is so slow that it takes many days overall to traverse from the early to late stages.
The number of lytic cycle-positive cells was not increased by more than twofold after TPA treatment of the KSHV-infected DMVEC cultures for 48 or 72 h, but the proportion of cells displaying CPE, late ORF-K8.1 protein expression, and DNA replication compartments was increased four- to fivefold by TPA treatment (not shown). Curiously, in contrast to PEL cell lines, the levels of vIL6-positive IFA signals in infected DMVEC cells relative to K8- or ZMP-A-positive cells was greatly reduced, both as a fraction of the total cells and by intensity of the IFA signal. However, in other studies (Chiou, submitted), we have found robust levels of expression of the virus-encoded angiogenic vGCR membrane signaling protein (1, 3), although only in the subset of lytically infected DMVEC cells.
Finally, based on all of the observed characteristics of the KSHV-infected DMVEC system, we may have to consider an alternative scenario in which all of the spindle cells are actually undergoing very slow lytic cycle progression, with latent episomal genomes and LANA1 expression being just the first and earliest stage. Perhaps all of the infected DMVEC have the potential to eventually go on to express lytic cycle proteins and develop CPE. Related to this model is the question of why the supposedly latently infected cells that convert to the lytic cycle occur primarily within localized clusters rather than sporadically. Do the cells with CPE simply represent those that have been infected the longest (or perhaps had time to rearrange their genomes in some way), or does the first cell that undergoes a switch into the lytic cycle produce localized paracrine effects that trigger adjacent cells to also convert to lytic infection, or could this phenomenon even represent superinfection of otherwise latently infected adjacent cells by highly cell-associated progeny virions from the first cell in the cluster that shows CPE?
| |
ACKNOWLEDGMENTS |
|---|
This study was were supported by research grants R01CA 73585, R01CA 81422, and P01CA 81400 to G.S.H. and P01 CA70062 to R.F.A. from the National Institutes of Health. J.S.C. was partially supported by training grant T32 CA09243 within the Johns Hopkins Department of Pharmacology and Molecular Sciences.
We thank Chris Boshoff (University College of London) and Bala Chandran (University of Kansas) for gifts of anti-KSHV MAbs before they were published and commercially available.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Virology Laboratories, Rm. 3M-08 Bunting-Blaustein Cancer Research Building, The Johns Hopkins University School of Medicine, 1650 Orleans St., Baltimore, MD 21231. Phone: (410) 955-8684. Fax: (410) 955-8685. E-mail: ghayward{at}jhmi.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350[CrossRef][Medline]. |
| 2. |
Arvanitakis, L.,
E. A. Mesri,
R. G. Nador,
J. W. Said,
A. S. Asch,
D. M. Knowles, and E. Cesarman.
1996.
Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.
Blood
88:2648-2654 |
| 3. | Bais, C., B. Santomasso, O. Coso, L. Arvanitakis, E. G. Raaka, J. S. Gutkind, A. S. Asch, E. Cesarman, M. C. Gerhengorn, and E. A. Mesri. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89[CrossRef][Medline]. |
| 4. |
Ballestas, M. E.,
P. A. Chatis, and K. M. Kaye.
1999.
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.
Science
284:641-644 |
| 5. |
Boshoff, C.,
S.-J. Gao,
L. E. Healy,
S. Matthews,
A. J. Thomas,
L. Coignet,
R. A. Warnke,
J. A. Strauchen,
E. Matutes,
O. W. Kamel,
P. S. Moore,
R. A. Weiss, and Y. Chang.
1998.
Establishing a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice.
Blood
91:1671-1679 |
| 6. |
Cannon, J. S.,
D. Cuifo,
A. L. Hawkins,
C. A. Griffin,
M. Borowitz,
G. S. Hayward, and R. F. Ambinder.
2000.
A new primary effusion lymphoma-derived cell line yields highly infectious Kaposi's sarcoma-associated herpesvirus supernatant.
J. Virol.
74:10187-10193 |
| 7. |
Cesarman, E.,
P. S. Moore,
P. H. Rao,
G. Inghirami,
D. M. Knowles, and Y. Chang.
1995.
In vitro establishment and characterization of two AIDS-related lymphoma cell lines containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.
Blood
86:2708-2714 |
| 8. | Chan, S. R., C. Bloomer, and B. Chandran. 1998. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. Virology 240:118-126[CrossRef][Medline]. |
| 9. |
Chang, Y.,
E. Cesarman,
M. S. Pessin,
F. Lee,
J. Culpepper,
D. M. Knowles, and P. S. Moore.
1994.
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science
266:1865-1869 |
| 10. |
Dupin, N.,
C. Fisher,
P. Kellam,
S. Ariad,
M. Tulliez,
N. Franck,
E. van Marck,
D. Salmon,
I. Gorin,
J.-P. Escande,
R. A. Weiss,
K. Alitalo, and C. Boshoff.
1999.
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.
Proc. Natl. Acad. Sci. USA
96:4546-4551 |
| 11. | Flore, O., S. Rafil, S. Ely, J. J. O'Leary, E. M. Hyjek, and E. Cesarman. 1998. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394:588-592[CrossRef][Medline]. |
| 12. |
Foreman, K. E.,
J. Friborg,
W.-P. Kong,
C. Woffendin,
P. J. Polverini,
B. J. Nickoloff, and G. J. Nabel.
1997.
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.
N. Engl. J. Med.
336:163-171 |
| 13. |
Kellam, P.,
D. Bourboulia,
N. Dupin,
C. Shotton,
C. Fisher,
S. Talbot,
C. Boshoff, and R. A. Weiss.
1999.
Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8.
J. Virol.
73:5149-5155 |
| 14. | Miller, G., L. Heston, E. Grogan, L. Gradoville, M. Rigsby, R. Sun, D. Shedd, V. M. Kushnaryov, S. Grossberg, and Y. Chang. 1997. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71:314-324[Abstract]. |
| 15. |
Moore, P. S.,
C. Boshoff,
R. A. Weiss, and Y. Chang.
1996.
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.
Science
274:1739-1744 |
| 16. | Moore, P. S., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N. Engl. J. Med. 332:1182-1185. |
| 17. |
Moses, A. V.,
K. N. Fish,
R. Ruhl,
P. P. Smith,
J. G. Strussenberg,
L. Zhu,
B. Chandran, and J. A. Nelson.
1999.
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.
J. Virol.
73:6892-6902 |
| 18. | Nicholas, J., V. R. Ruvolo, W. H. Burns, G. Sandford, X. Wan, D. Ciufo, S. B. Hendrickson, H.-G. Guo, G. S. Hayward, and M. S. Reitz. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3:287-292[CrossRef][Medline]. |
| 19. | Nicholas, J., J.-C. Zong, D. J. Alcendor, D. M. Ciufo, L. J. Poole, R. T. Sarisky, C. J. Chiou, X. Zhang, X. Wan, H.-G. Guo, M. S. Reitz, and G. S. Hayward. 1998. Novel organizational features, captured cellular genes and strain variability within the genome of KSHV/HHV8. J. Natl. Cancer Inst. Monogr. 23:79-88. |
| 20. | Orenstein, J., D. Ciufo, J. P. Zoeteweij, A. Blauvelt, and G. S. Hayward. 2000. Morphogenesis of HHV8 in primary human dermal microvascular endothelium and primary effusion lymphomas. Ultrastruct. Pathol. 24:291-300[CrossRef][Medline]. |
| 21. | Panyutich, E. A., J. W. Said, and S. A. Miles. 1998. Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS 12:467-472[CrossRef][Medline]. |
| 22. |
Poole, L. J.,
J.-C. Zong,
D. M. Ciufo,
D. J. Alcendor,
J. S. Cannon,
R. Ambinder,
J. Orenstein,
M. S. Reitz, and G. S. Hayward.
1999.
Comparison of genetic variability at multiple loci across the genomes of the major subgroups of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K 15 alleles at the right-hand end.
J. Virol.
73:6646-6660 |
| 23. |
Renne, R.,
D. Blackbourn,
D. Whitby,
J. Levy, and D. Ganem.
1998.
Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells.
J. Virol.
72:5182-5188 |
| 24. | Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346[CrossRef][Medline]. |
| 25. |
Russo, J. J.,
R. A. Bohenzky,
M.-C. Chien,
J. Chen,
M. Yan,
D. Maddalena,
J. P. Parry,
D. Peruzzi,
I. S. Edelman,
Y. Chang, and P. S. Moore.
1996.
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. USA
93:14862-14867 |
| 26. |
Sarid, R.,
O. Flore,
R. A. Bohenzky,
Y. Chang, and P. S. Moore.
1998.
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).
J. Virol.
72:1005-1012 |
| 27. |
Soulier, J.,
L. Grollet,
E. Oksenhendler,
P. Cacoub,
D. Cazals-Hatem,
P. Babinet,
M. F. d'Agay,
J. P. Clauvel,
M. Raphael,
L. Degos, et al.
1995.
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
Blood
86:1276-1280 |
| 28. |
Staskus, K. A.,
R. Sun,
G. Miller,
P. Racz,
A. Jaslowski,
C. Metroka,
H. Brett-Smith, and A. T. Haase.
1999.
Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
J. Virol.
73:4181-4187 |
| 29. |
Sturzl, M.,
C. C. Hohenadi,
C. Zeitz,
E. Castanos-Velez,
A. Wunderlich,
G. Ascheri,
P. Biberfeld,
P. Monini,
P. J. Browning, and B. Ensoli.
1999.
Expression of K13/v-FLIP gene of human herpesviruses 8 and apoptosis in Kaposi's sarcoma spindle cells.
J. Natl. Cancer Inst.
91:1725-1733 |
| 30. |
Sun, R.,
S.-F. Lin,
K. Staskus,
L. Gradoville,
E. Grogan,
A. Haase, and G. Miller.
1999.
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.
J. Virol.
73:2232-2242 |
| 31. |
Wu, F.,
J.-H. Ahn,
D. Alcendor,
W.-J. Jang,
J. Xiao,
S. D. Hayward, and G. S. Hayward.
2001.
Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.
J. Virol.
75:1487-1506 |
| 32. |
Zhu, F. X.,
T. Cusano, and Y. Yuan.
1999.
Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus.
J. Virol.
73:5556-5567 |
| 33. |
Zong, J.-C.,
D. M. Ciufo,
D. J. Alcendor,
X. Wan,
J. Nicholas,
P. Browning,
P. Rady,
S. K. Tyring,
J. Orenstein,
C. Rabkin,
I.-J. Su,
K. F. Powell,
M. Croxson,
K. E. Foreman,
B. J. Nickoloff,
S. Alkan, and G. S. Hayward.
1999.
High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple clades in different human populations.
J. Virol.
73:4156-4170 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»